CCN3-derrived peptides to treat liver injury
Ended Project Grant Awarded Last action
- Award ID
- R41DK116448
- Recipient
-
BLR Bio LLC UEI LJ12DM26TA49
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $342,514
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $56,824 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $285,690 |
Quick answers
Who received award R41DK116448?
R41DK116448 was awarded to BLR Bio LLC by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 20, 2018.
How much is award R41DK116448 worth?
$342,514 has been obligated on R41DK116448.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award